While this is not established in ACC tumors, de novo steroidogenesis has been shown to increase after treatment of androgen receptor–positive prostate cancer cells with IGF-2 via upregulated expression of steroid acute regulatory protein (StAR) as well as other steroidogenic enzymes [19]. The gene discussed is IGF2; the disease is prostate cancer.